{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T21:50:00Z","timestamp":1692913800312},"reference-count":73,"publisher":"Hogrefe Publishing Group","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Praxis"],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:p>Zusammenfassung. Im Alltag stellen K.o.-Mittel die praktizierenden \u00c4rzte nicht selten vor Herausforderungen. Besteht der Verdacht einer Substanzbeibringung, steht in erster Linie die Frage nach einer Involvierung der Rechtsmedizin im Raum. Bei unklaren Situationen oder fraglichen Delikten kann jedoch seitens der Patientinnen und Patienten der Wunsch einer Erstdiagnostik auf der Notfallstation bzw. in der Sprechstunde ge\u00e4ussert werden. Der Kliniker ist dabei mit einer Vielzahl m\u00f6glicher involvierter Substanzen, begrenzten analytischen Methoden und oftmals schwierig zu interpretierenden Resultaten konfrontiert. Im folgenden Artikel wird ein \u00dcberblick \u00fcber die diagnostischen M\u00f6glichkeiten sowie ihre Limitationen gegeben. H\u00e4ufig involvierte Substanzen, ihre Nachweisbarkeit und pharmakokinetische Besonderheiten werden vorgestellt. Besondere Aufmerksamkeit soll den im Alltag relevanten, praktischen Aspekten gelten.<\/jats:p>","DOI":"10.1024\/1661-8157\/a003306","type":"journal-article","created":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T09:19:01Z","timestamp":1569921541000},"page":"869-876","source":"Crossref","is-referenced-by-count":1,"title":["Verdacht auf K.o.-Mittel: Diagnostik in der Notfallstation und Praxis"],"prefix":"10.1024","volume":"108","author":[{"given":"Tim","family":"B\u00fchler","sequence":"first","affiliation":[{"name":"Abteilung f\u00fcr Klinische Pharmakologie & Toxikologie, Universit\u00e4tsspital Basel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmin","family":"Schmid","sequence":"additional","affiliation":[{"name":"Abteilung f\u00fcr Klinische Pharmakologie & Toxikologie, Universit\u00e4tsspital Basel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias E.","family":"Liechti","sequence":"additional","affiliation":[{"name":"Abteilung f\u00fcr Klinische Pharmakologie & Toxikologie, Universit\u00e4tsspital Basel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"101","reference":[{"key":"c1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(00)00191-5"},{"key":"c2","first-page":"14","volume":"13","author":"Pf\u00e4ffli M","year":"2013","journal-title":"Schweiz Med Forum"},{"key":"c3","first-page":"53","volume":"2","author":"Gerretsen M","year":"1979","journal-title":"Vet Hum Toxicol"},{"key":"c4","unstructured":"The meaning and origin of the expression: A Mickey Finn. 2019. https:\/\/www.phrases.org.uk\/meanings\/mickey-finn.html; letzter Zugriff: 24.04.2019."},{"key":"c5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jflm.2018.11.006"},{"key":"c6","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2018.08.034"},{"key":"c7","unstructured":"Neumeister B & B\u00f6hm O: Analytische Phase. In: (Hrsg.).Klinikleitfaden Labordiagnostik,6. Aufl.M\u00fcnchen; Elsevier: 2018. 13\u201315."},{"key":"c8","unstructured":"Pragst F: Pitfalls in hair analysis. Joint GTFCh\/TIAFT Symposium \u00abAnalytical Pitfalls and Trends in Clinical and Forensic Toxicology\u00bb, Analytica Conference in Munich; 2004."},{"key":"c9","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e318239a41a"},{"key":"c10","doi-asserted-by":"crossref","unstructured":"Sciotti MA, Hasan L, Scholer A, Jermann TM, Weber JM & Gygax D: Development and characterization of an enzymatic method for the rapid determination of gamma hydroxybutyric acid. Chimia (Aarau) 2010;64: 793\u2013798.","DOI":"10.2533\/chimia.2010.793"},{"key":"c11","unstructured":"B\u00dcHLMANN Laboratories AG: B\u00dcHLMANN GHB Enzymatic Assay. Sch\u00f6nbuch. 2019. https:\/\/www.buhlmannlabs.ch\/; letzter Zugriff: 25.06.2019."},{"key":"c12","unstructured":"Bundesamt f\u00fcr Gesundheit: Analysenliste (AL) der Schweiz. Stand 01.01.2019."},{"key":"c13","unstructured":"Laborbuch des Universit\u00e4tsspitals Basel. Analysenverzeichnis Labormedizin, Stand 27.08 .2018."},{"key":"c14","unstructured":"1Support-Center-Abrechnung:Interne Korrespondenz, Universit\u00e4tsspital Basel, 01.02.2019."},{"key":"c15","doi-asserted-by":"publisher","DOI":"10.2165\/00139709-200423010-00002"},{"key":"c16","doi-asserted-by":"publisher","DOI":"10.1186\/s13049-016-0299-z"},{"key":"c17","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X13666141210215423"},{"key":"c18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200101113440202"},{"key":"c19","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.07.010"},{"key":"c20","first-page":"4","volume":"44","author":"Liechti ME","year":"200","journal-title":"Internist"},{"key":"c21","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12863"},{"key":"c22","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2013.12.003"},{"key":"c23","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.11.014"},{"key":"c24","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1306"},{"key":"c25","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/28.8.625"},{"key":"c26","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1369.065"},{"key":"c27","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bkr023"},{"key":"c28","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000237944.57893.28"},{"key":"c29","doi-asserted-by":"publisher","DOI":"10.1177\/0091270002239707"},{"key":"c30","doi-asserted-by":"publisher","DOI":"10.1007\/BF00265954"},{"key":"c31","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/33.6.332"},{"key":"c32","unstructured":"Eidgen\u00f6ssisches Departement des Inneren:Verordnung des EDI \u00fcber die Verzeichnisse der Bet\u00e4ubungsmittel, psychotropen Stoffe, Vorl\u00e4uferstoffe und Hilfschemikalien. Bern: Stand 01.12.2016."},{"key":"c33","unstructured":"Eidgen\u00f6ssisches Departement des Inneren:Bundesgesetz \u00fcber die Bet\u00e4ubungsmittel und die psychotropen Stoffe. Bern: Stand 01.01.2018."},{"key":"c34","doi-asserted-by":"crossref","unstructured":"Swissmedic:Arzneimittelinformationen. Schweizerisches Heilmittelinstitut 2019. https:\/\/www.swissmedic.ch; letzter Zugriff: 26.06.2019.","DOI":"10.4414\/saez.2018.17387"},{"key":"c35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jflm.2008.08.014"},{"key":"c36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1992.tb04129.x"},{"key":"c37","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050113"},{"key":"c38","first-page":"161","volume":"119","author":"LeBeau MA","year":"2001","journal-title":"Fo"},{"key":"c39","doi-asserted-by":"publisher","DOI":"10.2174\/1872208309666150504143155"},{"key":"c40","doi-asserted-by":"publisher","DOI":"10.1520\/JFS15023J"},{"key":"c41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1556-4029.2009.01304.x"},{"key":"c42","doi-asserted-by":"publisher","DOI":"10.1093\/anatox\/35.1.8"},{"key":"c43","doi-asserted-by":"publisher","DOI":"10.4155\/bio.09.70"},{"key":"c44","doi-asserted-by":"publisher","DOI":"10.1016\/S0379-0738(02)00183-4"},{"key":"c45","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/30.6.360"},{"key":"c46","doi-asserted-by":"publisher","DOI":"10.1016\/S0379-0738(03)00043-4"},{"key":"c47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jflm.2014.07.008"},{"key":"c48","unstructured":"SCDAT:Richtlinien der Suchtstoffanalytik. Swiss Guidelines Committee for Drugs of Abuse Testing (SCDAT). 2012. http:\/\/www.sscc.ch\/scdat\/files\/Richtlinien_vers-DE_2012-11-15_mod2013-05-23.pdf; letzter Zugriff: 26.06.2019."},{"key":"c49","unstructured":"Alere Inc.Alere Triage\u00ae TOX Drug Screen Product Insert \u2013 Rapid Qualitative simultaneous detectionof drug and\/or the major urinary metabolites of 10 different drug classes (11 unique assays). San Diego; Alere Inc.: 2016."},{"key":"c50","first-page":"349","volume":"17","author":"Yaripour S","year":"2018","journal-title":"EXCLI J"},{"key":"c51","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-013-0292-0"},{"key":"c52","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2004.04.019"},{"key":"c53","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2018.1506130"},{"key":"c54","doi-asserted-by":"publisher","DOI":"10.3109\/15376516.2013.796034"},{"key":"c55","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31816791d7"},{"key":"c56","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/26.6.340"},{"key":"c57","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.1549"},{"key":"c58","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2006.10.015"},{"key":"c59","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-003-1896-z"},{"key":"c60","doi-asserted-by":"publisher","DOI":"10.3109\/15376516.2010.497976"},{"key":"c61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcfm.2004.08.005"},{"key":"c62","doi-asserted-by":"publisher","DOI":"10.1258\/acb.2011.011112"},{"key":"c63","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2011.10.024"},{"key":"c64","first-page":"2477","volume":"84","author":"Lucas CJ","year":"2018","journal-title":"Br"},{"key":"c65","doi-asserted-by":"publisher","DOI":"10.1373\/49.7.1114"},{"key":"c66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jflm.2017.02.005"},{"key":"c67","doi-asserted-by":"publisher","DOI":"10.1016\/j.yhbeh.2009.11.009"},{"key":"c68","doi-asserted-by":"publisher","DOI":"10.1081\/JA-200066814"},{"key":"c69","doi-asserted-by":"publisher","DOI":"10.1016\/S0740-5472(01)00215-X"},{"key":"c70","doi-asserted-by":"publisher","DOI":"10.1016\/S0740-5472(02)00223-4"},{"key":"c71","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1542\/peds.92.3.442","volume":"92","author":"Steinberg AD","year":"1993","journal-title":"Pediatrics"},{"key":"c72","unstructured":"Food and Drug Administration of the United States:List of Unapproved Drugs. 2011. https:\/\/www.fda.gov\/drugs\/; letzter Zugriff: 04.03.2019."},{"key":"c73","unstructured":"CPS-Citopharma.Pers\u00f6nliche Korrespondenzvom 04.02.2019."}],"container-title":["Praxis"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/econtent.hogrefe.com\/doi\/pdf\/10.1024\/1661-8157\/a003306","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T17:17:16Z","timestamp":1664558236000},"score":1,"resource":{"primary":{"URL":"https:\/\/econtent.hogrefe.com\/doi\/10.1024\/1661-8157\/a003306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":73,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["10.1024\/1661-8157\/a003306"],"URL":"https:\/\/doi.org\/10.1024\/1661-8157\/a003306","relation":{},"ISSN":["1661-8157","1661-8165"],"issn-type":[{"value":"1661-8157","type":"print"},{"value":"1661-8165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}